Literature DB >> 9683667

IgG receptor polymorphisms: risk factors for disease.

W van der Pol1, J G van de Winkel.   

Abstract

Two groups of receptors for immunoglobulin G (FcgammaR) can be distinguished. Endothelial cells and placental syncytiotrophoblasts express an MHC class I-like FcgammaR important for regulation of IgG half-life and IgG transport, respectively. FcgammaR expressed on leukocytes constitute a heterogeneous family of membrane bound and soluble proteins. The various FcgammaR (sub) classes of this family differ in ligand affinity and specificity, which is determined by primary structure, glycosylation, association with signaling subunits, and environmental factors (such as serine proteases). The finding that polymorphisms of FcgammaRIIa, FcgammaRIIIa, and FcgammaRIIIb critically affect interaction with antibodies has prompted analysis in patients which provided tantalizing evidence for the relevance of FcgammaR polymorphisms as risk factors for a number of infectious and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9683667     DOI: 10.1007/s002510050426

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  47 in total

1.  Human C-reactive protein does not bind to FcgammaRIIa on phagocytic cells.

Authors:  E Saeland; A van Royen; K Hendriksen; H Vilé-Weekhout; G T Rijkers; L A Sanders; J G van de Winkel
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Fcgamma receptor polymorphisms in populations in Ethiopia and Norway.

Authors:  L Van Den Berg; K M Myhr; B Kluge; C A Vedeler
Journal:  Immunology       Date:  2001-09       Impact factor: 7.397

Review 3.  The genetics of normal platelet reactivity.

Authors:  Thomas J Kunicki; Diane J Nugent
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

Review 4.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

5.  Targeting the endothelial progenitor cell surface proteome to identify novel mechanisms that mediate angiogenic efficacy in a rodent model of vascular disease.

Authors:  Catherine C Kaczorowski; Timothy J Stodola; Brian R Hoffmann; Anthony R Prisco; Pengyuan Y Liu; Daniela N Didier; Jamie R Karcher; Mingyu Liang; Howard J Jacob; Andrew S Greene
Journal:  Physiol Genomics       Date:  2013-09-10       Impact factor: 3.107

6.  Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations.

Authors:  Oivind Torkildsen; Egil Utsi; Svein Ivar Mellgren; Hanne F Harbo; Christian A Vedeler; Kjell-Morten Myhr
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

7.  Distribution of the FcgammaRIIIa 176 F/V polymorphism amongst healthy Chinese, Malays and Asian Indians in Singapore.

Authors:  K T Chong; W F Ho; S H Koo; Peter Thompson; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2006-09-19       Impact factor: 4.335

8.  Immunological status in the aetiology of recurrent otitis media with effusion: serum immunoglobulin levels, functional mannose-binding lectin and Fc receptor polymorphisms for IgG.

Authors:  Masja Straetemans; Selma P Wiertsema; Elisabeth A M Sanders; Ger T Rijkers; Kees Graamans; Bert van der Baan; Gerhard A Zielhuis
Journal:  J Clin Immunol       Date:  2005-01       Impact factor: 8.317

9.  Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.

Authors:  Rangaiah Shashidharamurthy; Fang Zhang; Aaron Amano; Aparna Kamat; Ravichandran Panchanathan; Daniel Ezekwudo; Cheng Zhu; Periasamy Selvaraj
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Evidence for non-random distribution of Fcgamma receptor genotype combinations.

Authors:  W-Ludo van der Pol; Marc D Jansen; Wim J Sluiter; Bart van de Sluis; Fredriek G J Leppers-van de Straat; Tetsuo Kobayashi; Rudi G J Westendorp; Tom W J Huizinga; Jan G J van de Winkel
Journal:  Immunogenetics       Date:  2003-06-26       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.